Baker Biotech Capital II Gp LLC

Avg. Two Year Performance

(11%) Avg. Purchase Return
(5%) Compound
56% Avg. Sale Return
25% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return7%(2%)5%(11%)(11%)
Purchase Success Rate8 of 147 of 149 of 149 of 148 of 14
Average Sale Return41%54%47%22%56%
Sale Success Rate1 of 11 of 11 of 11 of 11 of 1
Drugs » Drug Manufacturers - Other

Director, 10% Owner:

Holdings: 2.04M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Director, 10% Owner:

Holdings: 353.15K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Director, 10% Owner:

Holdings: 1.14M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Drug Manufacturers - Other

10% Owner:

Holdings: 435.85K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

10% Owner:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

10% Owner:

Holdings: 2.18M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--